CAXTON ASSOCIATES LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$710,000
+198.3%
6,347
+93.8%
0.06%
+40.9%
Q1 2020$238,000
-72.0%
3,275
+5.8%
0.04%
-25.4%
Q3 2018$850,000
+6.8%
3,096
-19.4%
0.06%
+47.5%
Q2 2018$796,000
+20.2%
3,842
-4.1%
0.04%
+17.6%
Q1 2018$662,0004,0070.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders